Systematic Financial Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Systematic Financial Management’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21M	Sell	667,883 -79,632	-11%	-$2.35M	0.42%	92
2026 Q1	$18.5M	Buy	747,515 +24,273	+3%	+$578K	0.42%	94
2025 Q4	$16.9M	Buy	723,242 +37,578	+5%	+$837K	0.4%	100
2025 Q3	$13.5M	Buy	685,664 +491,034	+252%	+$10.1M	0.33%	120
2025 Q2	$4.22M	Buy	194,630 +13,240	+7%	+$313K	0.11%	158
2025 Q1	$4.4M	Buy	+181,390	New	+$4.08M	0.13%	153
2020 Q3	–	Sell	-67,665	Closed	-$313K	–	294
2020 Q2	$313K	Buy	+67,665	New	+$304K	0.02%	333

Other funds holding CPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Systematic Financial Management's CPRX Position: Q2 2026 in Review

Systematic Financial Management reduced its Catalyst Pharmaceutical (CPRX) stake by 11% in Q2 2026, selling an estimated $2.35M and leaving 667,883 shares worth $21M. The position accounts for 0.42% of the portfolio, ranked #92.

Systematic Financial Management first reported a position in CPRX in Q2 2020 and has held it in 7 quarters since. 395 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

Systematic Financial Management held 667,883 shares of Catalyst Pharmaceutical worth $21M as of Q2 2026.
Systematic Financial Management sold 79,632 Catalyst Pharmaceutical shares in Q2 2026, an estimated $2.35M.
Catalyst Pharmaceutical made up 0.42% of Systematic Financial Management's portfolio in Q2 2026, its #92 holding.
Systematic Financial Management first reported a position in Catalyst Pharmaceutical in Q2 2020 and has held it in 7 quarters since.
395 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Systematic Financial Management's 13F filing for Q2 2026, filed 14 Aug 2026.